Show simple item record

dc.contributor.authorScherbaum, Norbert
dc.contributor.authorBonnet, Udo
dc.contributor.authorHafermann, Henning
dc.contributor.authorSchifano, Fabrizio
dc.contributor.authorBender, Stefan
dc.contributor.authorGrigoleit, Torsten
dc.contributor.authorKuhn, Jens
dc.contributor.authorNyhuis, Peter
dc.contributor.authorPreuss, Ulrich W
dc.contributor.authorReymann, Gerhard
dc.contributor.authorSchneider, Udo
dc.contributor.authorShibata, Jo
dc.contributor.authorSpecka, Michael
dc.date.accessioned2021-05-18T10:15:00Z
dc.date.available2021-05-18T10:15:00Z
dc.date.issued2021-04-23
dc.identifier.citationScherbaum , N , Bonnet , U , Hafermann , H , Schifano , F , Bender , S , Grigoleit , T , Kuhn , J , Nyhuis , P , Preuss , U W , Reymann , G , Schneider , U , Shibata , J & Specka , M 2021 , ' Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany ' , Frontiers in Psychiatry , vol. 12 , 648273 . https://doi.org/10.3389/fpsyt.2021.648273
dc.identifier.issn1664-0640
dc.identifier.otherPubMedCentral: PMC8102785
dc.identifier.urihttp://hdl.handle.net/2299/24499
dc.description© 2021 Scherbaum, Bonnet, Hafermann, Schifano, Bender, Grigoleit, Kuhn, Nyhuis, Preuss, Reymann, Schneider, Shibata and Specka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). https://creativecommons.org/licenses/by/4.0/
dc.description.abstractBackground: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tried to cope with possible drug availability issues by increasingly obtaining drugs via the internet, replacing their preferred illegal drug with novel psychoactive substances, including new synthetic opioids (NSO), and/or by seeking drug treatment. Methods: A questionnaire was anonymously filled in by subjects with substance-related disorders, typically attending low-threshold settings, drug consumption facilities, and inpatient detoxification wards from a range of locations in the Western part of Germany. Participants had to both identify their main drug of abuse and to answer questions regarding its availability, price, quality, and routes of acquisition. Results: Data were obtained from 362 participants. The most frequent main substances of abuse were cannabis (n = 109), heroin (n = 103), and cocaine (n = 75). A minority of participants reported decreased availability (8.4%), increased price (14.4%), or decreased quality (28.3%) of their main drug. About 81% reported no change in their drug consumption due to the COVID-19 pandemic and the lockdown. A shift to the use of novel psychoactive substances including NSO were reported only by single subjects. Only 1-2% of the participants obtained their main drug via the web. Discussion: Present findings may suggest that recent pandemic-related imposed restrictions may have not been able to substantially influence either acquisition or consumption of drugs within the context of polydrug users (including opiates) attending a range of addiction services in Germany.en
dc.format.extent7
dc.format.extent198528
dc.language.isoeng
dc.relation.ispartofFrontiers in Psychiatry
dc.subjectCOVID-19
dc.subjectcannabis
dc.subjectcocaine
dc.subjectdrug availability
dc.subjectheroin
dc.subjectnovel psychotropic substances
dc.subjectnovel synthetic opioids
dc.subjectpregabalin
dc.subjectPsychiatry and Mental health
dc.titleAvailability of Illegal Drugs During the COVID-19 Pandemic in Western Germanyen
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionUniversity of Hertfordshire
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85105604770&partnerID=8YFLogxK
rioxxterms.versionofrecord10.3389/fpsyt.2021.648273
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record